HOLX

Hologic
D

HOLX

64.750
USD
-0.54
(-0.83%)
مغلق
حجم التداول
49,375
الربح لكل سهم
4
العائد الربحي
-
P/E
27
حجم السوق
14,429,229,679
أصول ذات صلة
ABT
ABT
0.210
(0.16%)
134.280 USD
BDX
BDX
-0.560
(-0.32%)
176.660 USD
DGX
DGX
-0.610
(-0.35%)
176.010 USD
ISRG
ISRG
3.16
(0.58%)
543.88 USD
R
RGEN
0.490
(0.39%)
127.440 USD
SYK
SYK
-5.11
(-1.30%)
386.66 USD
T
TDOC
-0.05500
(-0.66%)
8.29500 USD
TMO
TMO
1.69
(0.40%)
429.33 USD
المزيد
الأخبار المقالات

العنوان: Hologic

القطاع: Healthcare
الصناعة: Medical Instruments & Supplies
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.